期刊文献+

乌司它丁对川崎病患儿血清TNF-α、IL-6表达影响研究 被引量:1

Effect of Ulinastatin to TNF-α and IL-6 in Serum on Children with KD
下载PDF
导出
摘要 目的:观察乌司它丁对川崎病患儿血清及TNF-α及IL-6的影响,探讨其对川崎病的辅助治疗作用。方法:74名川崎病患儿,随机分为治疗组及对照组,两组患儿均采取丙种球蛋白冲击、阿司匹林避热抗凝等治疗,治疗组另给予乌司它丁10 000U/d.kg,连续2周,治疗前后观察两组患儿血清TNF-α及IL-6的表达差异。结果:治疗前两组患儿血清TNF-α、IL-6表达水平无差异,2周后治疗组血清TNF-α、IL-6表达水平低于对照组。结论:乌司它丁能够降川崎病患儿血清TNF-α、IL-6的表达水平。 Objective:To observed the effect ofulinastatin to tumor necrosis factora(TNF-α and interleukin 6(IL-6 )in serum on children with kawasaki disease(KD),and investigate subsidiary therapeutical effect in KD.Methods:74 children with KD were randomly divid into control groups(CG) and experimental group(EG),the treatment of stosstherapy with gamma globulin and anticoagulant with aspirin were take in all patients, the paitients in EG received additional drug treatment with 1000U ulinastatin/d.kg in two weeks,the concentration of TNF-α and IL-6 in serum were measure in two groups.Results:The the concentration of TNF-α and IL-6 in serum were identical in two groups before therapy, and in comparison with CG,the concentration of TNF-α and IL-6 in serum were higher in EG after two weeks.Conclnslon:Ulinastatin could lower the expression of TNF-α and IL-6 in serum on children with KD.
作者 凌丽
出处 《中国医药导刊》 2010年第7期1185-1186,共2页 Chinese Journal of Medicinal Guide
关键词 川崎病 乌司它丁 肿瘤坏死因子 白细胞介素6 Kawasaki disease Ulinastatin Tumor necrosis factorα Interleukin 6
  • 相关文献

参考文献7

二级参考文献19

  • 1蔡后荣,张杏书,刘布俊,李春宁,彭晓东.血清可溶性IL-2R检测在结缔组织病中的应用[J].上海免疫学杂志,1993,13(4):216-218. 被引量:9
  • 2王翠华.川崎病患儿退热后应用丙种球蛋白治疗剂量与预后关系探讨[J].中国实用儿科杂志,2006,21(6):442-443. 被引量:8
  • 3刘颖.川崎病患儿PS、ES、VEGF血清含量变化的研究[J].中国妇幼保健,2006,21(18):2538-2539. 被引量:9
  • 4Satou GM, Giamelli J, Gewitz MH. Kawasaki disease: diagnosis, management, and long- term implications. Cardiol Rev, 2007, 15 (4): 163
  • 5Hui - Yuen JS, Duong TT, Yeung RS. TNF - alpha is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J Immunol, 2006, 176 (10) : 6294
  • 6Newburger JW, Takahashi M, Gerber MA et al. Diagnosis, Treatment, and Long- Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics, 2004, 114 (6): 1708
  • 7Freeman AF, Shulman ST. Kawasaki Disease: Summary of the American Heart Association Guidelines. Am Fam Physician, 2006, 74 (7): 1141
  • 8Baer AZ, Rubin LG Shapiro CA et al. Prevalence of coronary artery lesions on the initial echoeardiogram in Kawasaki syndrome. Arch Pediatr Adolesc Med, 2006, 160 (7) : 686
  • 9Okada Y, Ikeda K, Yamanaka O et al. TNFalpha suppression of corneal epithelium migration. Mol Vis, 2007, 14 (13) : 1428
  • 10Stenbog EV, Windelborg B, Horlyck Aet al. The effect of TNFalpha blockade in complicated, refractory Kawasaki disease. Scand J Rheumatol, 2006, 35 (4): 318

共引文献25

同被引文献27

  • 1张伟,李秋,赵晓东,唐雪梅,王晓刚,王墨,吴道奇,欧茜,杨锡强.942例川崎病的临床分析[J].中华儿科杂志,2006,44(5):324-328. 被引量:147
  • 2陈茂荣,杨运刚.甲基泼尼松龙治疗川崎病的疗效及对冠状动脉影响的探讨[J].临床儿科杂志,2006,24(6):520-522. 被引量:7
  • 3王古岩,何爱霞,王明义,金华,李立环.乌司他丁对非体外循环冠状动脉旁路移植术患者内皮功能的影响[J].中国循环杂志,2007,22(2):107-109. 被引量:3
  • 4Fury W, Tremoulet AH, Watson VE, et al. Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance[J]. Hum Immunol, 2010, 71(9): 865-873.
  • 5Nakamum Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in japan: resuits of the 2009-2010 nationwide survey[J]. J Epidemiol, 2012, 22(3): 216-221.
  • 6Prieto TL, Cuesta RM, Guillen MS, et al. Kawasaki disease: diagnosis and treatment[J]. An Pediatr(Barc), 2010, 73(1): 25-30.
  • 7Freemman AF, Shulman ST. Refractory Kawasaki disease[J]. Pediatr Infect Dis J, 2004, 23(5): 463-464.
  • 8Jibiki T, Kato I, shiohama T, et al. Intravenous immune globulin plus corticosteroids in refractory Kawasaki diseas[J]. Pedio Int, 2011, 53(5): 729-735.
  • 9Suzuki H, Terai M, Hamada H, et al. Cyclosporin A treatment for Kawasaki disease refractory to initialand additional intravenous immunoglobulin[J]. Pediatr Intfect Dis J, 2011, 30(10): 871-876.
  • 10Ravelli A, Magni-Manzoni S, Pistorio A, et al. Preliminary diagnosis guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis[J]. J Pediatr, 2005, 146(5): 598-604.

引证文献1

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部